An introduction to new advances in diabetes

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue SUPPL. 1, 2002, Pages

  Leslie, R D G ^a   Pozzilli, P ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Blood pressure; Cholesterol; Glucose; Insulin; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ATENOLOL; AUTOANTIGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; NISOLDIPINE; NITRENDIPINE; PHENOL; PLACEBO; PROTAMINE; RAMIPRIL; SIMVASTATIN; THIAZIDE DIURETIC AGENT; ZINC ION;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INACTIVATION; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT PLANNING; UNITED KINGDOM; VISUAL IMPAIRMENT;

EID: 0036105329     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.203     Document Type: Article

References (31)

1. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
2. Efficacy of inhaled human insulin in type 1 diabetes mellitus
3. Pharmacodynamics of oral insulin in healthy volunteers
4. Oral insulin metformin combination therapy for treatment of type 2 diabetes
5. A comparison of oral insulin versus s.c. injection in type 2 diabetic patients
6. Amogen driven bystander suppression after oral administration of antigens
7. Oral tolerance immune mechanisms and treatment of autoimmune disease
8. Prevention of insulin dependent diabetes mellitus. 1998
9. No effect of oral insulin on residual beta-cell function in recent-onset Type 1 diabetes
10. Cytokine production by lymphocytes from type 1 diabetic patients treated with oral insulin
11. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus
12. Hyperglycaemia and microvascular and macrovascular disease in diabetes
13. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
14. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial
15. The MiniMed Continuous Glucose Monitoring System (CGMS)
16. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
17. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
18. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
19. Randomised double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. (SYS-EUR trial)
20. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension (ABCD trial)
21. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
22. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
23. Effect of Ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
24. Shattock Lecture: Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
25. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
26. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction
27. Vitamin E supplementation and cardiovascular events in high-risk patients
28. Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
29. Aspirin effects on mortality and morbidity in patients with diabetes mellitus
30. Final report on the aspirin component of the ongoing Physicians' Health Study
31. Aspirin as an antiplatelet drug